To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ADAM15TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
593 representative clones for gene ADAM15 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AY560598   .a 1 to 2946 1 to 2946 K224T tiling clone,   2946/2946
(100 %)
2 diff
(100.0 %id)
NM_207196.1   .a 1 to 2967 1 to 2967 exact RefSeq,   2967/2967
(100 %)
3 diff
(99.9 %id)
AY560596   .b 1 to 2877 1 to 2877 K224T tiling clone,   2877/2877
(100 %)
2 diff
(100.0 %id)
NM_207194.1   .b 1 to 2898 1 to 2898 exact RefSeq,   2898/2898
(100 %)
3 diff
(99.9 %id)
AU142177 thyroid gland .b 602 to 1256 2 to 654   capped   653/727
(89 %)
9 diff
(98.8 %id)
AW673396 cervix .b 877 to 1256 1 to 380       380/380
(100 %)
9 diff
(97.7 %id)
BM724288 eye, fetal eye .b 1113 to 1850 1 to 737   tiling clone, Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 737/738
(99 %)
11 diff
(98.6 %id)
BI024775 marrow .b 2104 to 2497 394 to 1       394/394
(100 %)
1 diff
(99.8 %id)
BM680419 eye, fetal eye .b 2152 to 2894 757 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 739/739
(100 %)
5 diff
(99.4 %id)
DB382676 thyroid gland .b 2397 to 2894 495 to 1       495/499
(99 %)
7 diff
(98.6 %id)
AW675746 cervix .b 2399 to 2894 498 to 4       495/498
(99 %)
1 diff
(99.8 %id)
AY560597   .c 1 to 2874 1 to 2874 K224T tiling clone,   2874/2874
(100 %)
2 diff
(100.0 %id)
NM_207195.1   .c 1 to 2895 1 to 2895 exact RefSeq,   2895/2895
(100 %)
3 diff
(99.9 %id)
BQ689615 ductal carcinoma, cell line, Pancreas .c 1569 to 2436 1 to 867   tiling clone,   867/881
(98 %)
4 diff
(99.6 %id)
BG697219 skin .c 1743 to 2442 1 to 699       699/699
(100 %)
4 diff
(99.5 %id)
CA453985   .c 1768 to 2627 1 to 870       870/872
(99 %)
16 diff
(98.2 %id)
BG679224 skin, squamous cell carcinoma .c 1780 to 2487 1 to 701       701/716
(97 %)
11 diff
(98.5 %id)
AL120796 melanoma (MeWo cell line) .c 2027 to 2531 1 to 505       505/505
(100 %)
0 diff
(100 %id)
CA450048 Human Lung Epithelial cells, lung .c 2280 to 2892 631 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 613/613
(100 %)
9 diff
(98.6 %id)
DC334414 hippocampus .d 1 to 533 1 to 536   tiling clone,   536/536
(100 %)
4 diff
(99.3 %id)
TI_57201219   .d 11 to 760 63 to 813       751/813
(92 %)
8 diff
(99.1 %id)
AY560599   .d 15 to 2963 1 to 2949 K191T tiling clone,   2949/2949
(100 %)
2 diff
(100.0 %id)
NM_207197.1   .d 15 to 2984 1 to 2970 exact RefSeq,   2970/2970
(100 %)
3 diff
(99.9 %id)
DA334632 hippocampus .d 16 to 588 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BI823964 pooled brain, lung, testis .d 16 to 760 1 to 746       746/746
(100 %)
2 diff
(99.8 %id)
DA110612 cerebellum .d 18 to 574 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA297436 hippocampus .d 18 to 595 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DB179179 kidney, tumor tissue .d 18 to 561 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA343692 substantia nigra .d 20 to 573 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA230476 brain .d 25 to 640 2 to 617   capped   616/616
(100 %)
0 diff
(100 %id)
DA286637 corpus callosum .d 25 to 594 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA094709 cerebellum .d 26 to 588 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA112227 cerebellum .d 26 to 599 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA197826 brain .d 26 to 533 2 to 509   capped   508/508
(100 %)
0 diff
(100 %id)
DA280425 corpus callosum .d 26 to 562 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA451058 tongue, tumor tissue .d 26 to 574 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA475546   .d 26 to 516 2 to 492   capped   491/491
(100 %)
0 diff
(100 %id)
DA480124   .d 26 to 377 2 to 353   capped   352/352
(100 %)
0 diff
(100 %id)
DA575525   .d 26 to 596 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA739013   .d 26 to 526 2 to 502   capped   501/501
(100 %)
0 diff
(100 %id)
DA920687 small intestine .d 26 to 588 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB159265 thymus .d 26 to 604 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DB209400 trachea .d 26 to 298 2 to 274   capped   273/273
(100 %)
0 diff
(100 %id)
DB269314 uterus .d 26 to 579 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA050871   .d 31 to 284 2 to 255   capped   254/254
(100 %)
0 diff
(100 %id)
DA127154 cerebellum .d 31 to 612 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DA313343 hippocampus .d 31 to 474 2 to 445   capped   444/444
(100 %)
0 diff
(100 %id)
DA446805 tongue, tumor tissue .d 31 to 602 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA479814   .d 31 to 474 2 to 445   capped   444/444
(100 %)
0 diff
(100 %id)
DA808021 brain .d 31 to 533 2 to 504   capped   503/503
(100 %)
0 diff
(100 %id)
DB000361 breast, tumor tissue .d 31 to 509 2 to 480   capped   479/479
(100 %)
0 diff
(100 %id)
DB095629 testis .d 31 to 583 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DB274374 uterus .d 31 to 273 2 to 244   capped   243/243
(100 %)
0 diff
(100 %id)
DA445631 tongue, tumor tissue .d 33 to 604 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA447767 tongue, tumor tissue .d 33 to 444 2 to 413   capped   412/412
(100 %)
0 diff
(100 %id)
BP253527 Kidney .d 33 to 613 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA887239   .d 33 to 589 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA047099   .d 34 to 828 2 to 800   tiling clone, capped   797/804
(99 %)
13 diff
(98.4 %id)
DA424593   .d 34 to 509 2 to 477   capped   476/476
(100 %)
0 diff
(100 %id)
DA655109   .d 34 to 605 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA869024 Prostate .d 34 to 409 2 to 377   capped   376/376
(100 %)
0 diff
(100 %id)
DA884235   .d 34 to 582 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DB101233 thymus .d 34 to 274 2 to 242   capped   241/241
(100 %)
0 diff
(100 %id)
BX383217   .d 36 to 727 1 to 691       691/691
(100 %)
4 diff
(99.5 %id)
AW732352 Kidney, renal cell adenocarcinoma .d 36 to 652 1 to 617       617/617
(100 %)
0 diff
(100 %id)
DA298885 hippocampus .d 38 to 610 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA447317 tongue, tumor tissue .d 38 to 357 2 to 321   capped   320/320
(100 %)
0 diff
(100 %id)
BP252036 Kidney .d 42 to 625 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
BP253070 Kidney .d 42 to 623 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA219338 brain .d 43 to 604 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA380244 thalamus .d 43 to 587 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA433799 tongue, tumor tissue .d 43 to 417 2 to 376   capped   375/375
(100 %)
0 diff
(100 %id)
DA476551   .d 43 to 608 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BQ935151 carcinoma, cell line, Prostate .d 43 to 766 1 to 725       725/957
(75 %)
9 diff
(99.1 %id)
BU543665 carcinoma, cell line, Prostate .d 43 to 772 1 to 734       731/867
(84 %)
5 diff
(99.5 %id)
DA882860   .d 43 to 587 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA999745 breast, tumor tissue .d 43 to 533 2 to 492   capped   491/491
(100 %)
0 diff
(100 %id)
DA656762   .d 44 to 597 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
BU153394 large cell carcinoma, lung .d 45 to 786 1 to 750       750/923
(81 %)
15 diff
(98.4 %id)
DA009799 adrenal gland .d 46 to 614 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA027348   .d 46 to 616 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA039026 bladder .d 46 to 296 2 to 252   capped   251/251
(100 %)
0 diff
(100 %id)
DA219423 brain .d 46 to 558 2 to 514   capped   513/513
(100 %)
0 diff
(100 %id)
DA268492 caudate nucleus .d 46 to 533 2 to 489   capped   488/488
(100 %)
0 diff
(100 %id)
DA450260 tongue, tumor tissue .d 46 to 598 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA452462 tongue, tumor tissue .d 46 to 600 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA472688   .d 46 to 579 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DA499408 brain .d 46 to 613 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA503925 brain .d 46 to 597 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA648070   .d 46 to 545 2 to 501   capped   500/500
(100 %)
0 diff
(100 %id)
DA685304   .d 46 to 496 2 to 452   capped   451/451
(100 %)
0 diff
(100 %id)
DA748273   .d 46 to 579 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DA775603 brain .d 46 to 546 2 to 502   capped   501/501
(100 %)
0 diff
(100 %id)
DA883037   .d 46 to 604 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA962545 stomach .d 46 to 554 2 to 510   capped   509/509
(100 %)
0 diff
(100 %id)
DA989871 synovial membrane tissue from rheumatioidarthritis .d 46 to 556 2 to 512   capped   511/511
(100 %)
0 diff
(100 %id)
DB149217 thymus .d 46 to 255 2 to 211   capped   210/210
(100 %)
0 diff
(100 %id)
DB172255 kidney, tumor tissue .d 46 to 533 2 to 489   capped   488/488
(100 %)
0 diff
(100 %id)
DA685985   .d 48 to 297 2 to 251   capped   250/250
(100 %)
0 diff
(100 %id)
DA749416   .d 59 to 300 2 to 243   capped   242/242
(100 %)
0 diff
(100 %id)
DA917059 small intestine .d 59 to 579 2 to 522   capped   521/521
(100 %)
0 diff
(100 %id)
BX374925 Neuroblastoma Cot 25-normalized .d 63 to 962 1 to 898       898/898
(100 %)
9 diff
(99.0 %id)
DA887045   .d 63 to 619 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BU845588 ovary, teratocarcinoma, cell line .d 65 to 859 1 to 800       800/896
(89 %)
10 diff
(98.9 %id)
CA455142   .d 65 to 789 1 to 728       728/920
(79 %)
11 diff
(98.9 %id)
DB032721 testis .d 65 to 602 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA481648   .d 67 to 630 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA879453 Prostate .d 67 to 597 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
TI_154187401   .d 68 to 938 126 to 984       859/954
(90 %)
21 diff
(97.8 %id)
CF125928 Chondrosarcoma Lung Metastasis cell lines, lung .d 69 to 775 1 to 707       707/707
(100 %)
3 diff
(99.6 %id)
DA416697 thalamus .d 73 to 606 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DA053535   .d 74 to 533 2 to 461   capped   460/460
(100 %)
0 diff
(100 %id)
DA186867 amygdala .d 74 to 579 2 to 507   capped   506/506
(100 %)
0 diff
(100 %id)
DA235823 brain .d 74 to 655 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DA243599 brain .d 74 to 646 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA323701 hippocampus .d 74 to 361 2 to 289   capped   288/288
(100 %)
0 diff
(100 %id)
DA333926 hippocampus .d 74 to 646 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA450882 tongue, tumor tissue .d 74 to 634 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA619763   .d 74 to 670 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
DA861043 placenta .d 74 to 509 2 to 437   capped   436/436
(100 %)
0 diff
(100 %id)
DA866618 Prostate .d 74 to 509 2 to 437   capped   436/436
(100 %)
0 diff
(100 %id)
DA870621 Prostate .d 74 to 613 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA954664 Spleen .d 74 to 441 2 to 369   capped   368/368
(100 %)
0 diff
(100 %id)
DA989750 synovial membrane tissue from rheumatioidarthritis .d 74 to 604 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
DB089884 testis .d 74 to 624 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BX343231   .d 75 to 1029 1 to 940       920/944
(97 %)
31 diff
(96.8 %id)
BY797453 eye .d 76 to 686 1 to 611       611/611
(100 %)
6 diff
(99.1 %id)
DA598877   .d 78 to 533 2 to 457   capped   456/456
(100 %)
0 diff
(100 %id)
DC381784 placenta .d 78 to 643 1 to 566       566/566
(100 %)
0 diff
(100 %id)
DA048902   .d 79 to 618 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA204812 brain .d 79 to 658 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA443168 tongue, tumor tissue .d 79 to 604 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
BG491109 large cell carcinoma, lung .d 79 to 934 1 to 861       861/861
(100 %)
28 diff
(96.8 %id)
DA700767   .d 79 to 533 2 to 456   capped   455/455
(100 %)
0 diff
(100 %id)
DA928591 small intestine .d 79 to 645 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB231240 trachea .d 79 to 545 2 to 468   capped   467/467
(100 %)
0 diff
(100 %id)
BP252483 Kidney .d 80 to 661 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP256899 Kidney .d 80 to 661 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP314160 mammary gland .d 80 to 661 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BM822157 stomach .d 80 to 573 1 to 494       494/494
(100 %)
0 diff
(100 %id)
DA044424 bladder .d 81 to 643 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA049755   .d 81 to 406 2 to 327   capped   326/326
(100 %)
0 diff
(100 %id)
DA051750   .d 81 to 616 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DA083691 cerebellum .d 81 to 533 2 to 454   capped   453/453
(100 %)
0 diff
(100 %id)
DA115667 cerebellum .d 81 to 633 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA128818 cerebellum .d 81 to 681 2 to 602   capped   601/601
(100 %)
0 diff
(100 %id)
DA167756 amygdala .d 81 to 641 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA200266 brain .d 81 to 604 2 to 525   capped   524/524
(100 %)
0 diff
(100 %id)
DA200962 brain .d 81 to 663 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DA209078 brain .d 81 to 604 2 to 525   capped   524/524
(100 %)
0 diff
(100 %id)
DA238326 brain .d 81 to 597 2 to 518   capped   517/517
(100 %)
0 diff
(100 %id)
DA332969 hippocampus .d 81 to 671 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
DA379432 thalamus .d 81 to 579 2 to 500   capped   499/499
(100 %)
0 diff
(100 %id)
DA414300 thalamus .d 81 to 597 2 to 518   capped   517/517
(100 %)
0 diff
(100 %id)
DA423896   .d 81 to 556 2 to 477   capped   476/476
(100 %)
0 diff
(100 %id)
DA435321 tongue, tumor tissue .d 81 to 658 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA435420 tongue, tumor tissue .d 81 to 653 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA436235 tongue, tumor tissue .d 81 to 640 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA437224 tongue, tumor tissue .d 81 to 673 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
DA438717 tongue, tumor tissue .d 81 to 669 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DA451061 tongue, tumor tissue .d 81 to 333 2 to 254   capped   253/253
(100 %)
0 diff
(100 %id)
DA454567 tongue, tumor tissue .d 81 to 621 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DA455928 tongue, tumor tissue .d 81 to 632 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA473859   .d 81 to 637 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA481119   .d 81 to 631 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA619985   .d 81 to 649 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA620556   .d 81 to 659 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA685169   .d 81 to 613 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DA702358   .d 81 to 556 2 to 477   capped   476/476
(100 %)
0 diff
(100 %id)
DA702568   .d 81 to 496 2 to 417   capped   416/416
(100 %)
0 diff
(100 %id)
DA707366   .d 81 to 632 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA711031   .d 81 to 629 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA714176   .d 81 to 646 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA742640   .d 81 to 604 2 to 525   capped   524/524
(100 %)
0 diff
(100 %id)
DA743331   .d 81 to 579 2 to 500   capped   499/499
(100 %)
0 diff
(100 %id)
DA762315 tongue .d 81 to 630 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA778976 brain .d 81 to 657 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
CV573684 cornea, eye .d 81 to 664 1 to 584       584/584
(100 %)
0 diff
(100 %id)
DA853362 placenta .d 81 to 630 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA881568   .d 81 to 630 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA882512   .d 81 to 626 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA882814   .d 81 to 634 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA883943   .d 81 to 579 2 to 500   capped   499/499
(100 %)
0 diff
(100 %id)
DA884416   .d 81 to 579 2 to 500   capped   499/499
(100 %)
0 diff
(100 %id)
DA888074   .d 81 to 630 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA888401   .d 81 to 644 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA889775   .d 81 to 533 2 to 454   capped   453/453
(100 %)
0 diff
(100 %id)
DA921232 small intestine .d 81 to 579 2 to 500   capped   499/499
(100 %)
0 diff
(100 %id)
DA934258 Spleen .d 81 to 630 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA999234 breast, tumor tissue .d 81 to 533 2 to 454   capped   453/453
(100 %)
0 diff
(100 %id)
DB000024 breast, tumor tissue .d 81 to 533 2 to 454   capped   453/453
(100 %)
0 diff
(100 %id)
DB007795 cervix, tumor tissue .d 81 to 631 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB229154 trachea .d 81 to 670 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DB243031 stomach, tumor tissue .d 81 to 637 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB253778 uterus .d 81 to 579 2 to 500   capped   499/499
(100 %)
0 diff
(100 %id)
DB290526 uterus .d 81 to 661 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BQ688178 ductal carcinoma, cell line, Pancreas .d 87 to 733 1 to 647       647/975
(66 %)
11 diff
(98.9 %id)
BQ691836 ductal carcinoma, cell line, Pancreas .d 87 to 789 1 to 705       705/923
(76 %)
10 diff
(99.0 %id)
BQ691738 ductal carcinoma, cell line, Pancreas .d 87 to 728 1 to 644       644/927
(69 %)
6 diff
(99.4 %id)
CN267278 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 88 to 232 1 to 145       145/145
(100 %)
0 diff
(100 %id)
DA620345   .d 91 to 685 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
DA479467   .d 93 to 655 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BI254331 cervical carcinoma cell line, cervix .d 94 to 972 1 to 881       881/882
(99 %)
18 diff
(98.0 %id)
BI772573 pooled lung and spleen .d 95 to 857 32 to 789       758/806
(94 %)
9 diff
(98.9 %id)
TI_57177570   .d 95 to 857 32 to 789       758/806
(94 %)
9 diff
(98.9 %id)
BQ879137 ductal carcinoma, cell line, Pancreas .d 97 to 791 1 to 702       699/938
(74 %)
8 diff
(99.2 %id)
BU145326 ductal carcinoma, cell line, Pancreas .d 97 to 741 1 to 646       646/940
(68 %)
13 diff
(98.7 %id)
BU150083 ductal carcinoma, cell line, Pancreas .d 97 to 773 1 to 683       680/912
(74 %)
8 diff
(99.2 %id)
DR000006   .d 98 to 743 1 to 646       646/646
(100 %)
4 diff
(99.4 %id)
CA455080   .d 101 to 914 1 to 821       821/908
(90 %)
12 diff
(98.7 %id)
BI333578 cervical carcinoma cell line, cervix .d 104 to 775 1 to 670       670/670
(100 %)
3 diff
(99.6 %id)
CV027540 mixed .d 116 to 811 1 to 695       695/698
(99 %)
10 diff
(98.6 %id)
CA487950   .d 1698 to 2515 1 to 821       821/874
(93 %)
10 diff
(98.9 %id)
BF856289 prostate_normal .d 1965 to 2439 474 to 2     Submitted on the opposite strand 476/485
(98 %)
8 diff
(98.4 %id)
CN399722 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 2144 to 2866 1 to 723       723/723
(100 %)
3 diff
(99.6 %id)
TI_149311984   .d 2229 to 2980 847 to 103       745/1019
(73 %)
11 diff
(99.0 %id)
TI_149286257   .d 2253 to 2981 801 to 81   tiling clone, AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 721/785
(91 %)
12 diff
(98.5 %id)
BM977714 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 2295 to 2974 703 to 25   AAA   679/685
(99 %)
2 diff
(99.8 %id)
BM971880 lung .d 2347 to 2981 653 to 19   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 635/635
(100 %)
0 diff
(100 %id)
AY560601   .e 1 to 3091 1 to 3091 K224T tiling clone,   3091/3091
(100 %)
2 diff
(100.0 %id)
AY560600   .f 1 to 3088 1 to 3088 K224T tiling clone,   3088/3088
(100 %)
2 diff
(100.0 %id)
DC412729 kidney, tumor tissue .g 1 to 551 2 to 553   tiling clone,   553/553
(100 %)
1 diff
(99.9 %id)
DC345415 tongue, tumor tissue .g 20 to 531 1 to 512       512/512
(100 %)
0 diff
(100 %id)
DC358663 lung .g 20 to 609 1 to 591       591/591
(100 %)
1 diff
(99.9 %id)
AK296925 tongue, tumor tissue .g 55 to 2732 1 to 2678   tiling clone,   2678/2678
(100 %)
3 diff
(99.9 %id)
DC347502 tongue, tumor tissue .g 55 to 602 1 to 548       548/548
(100 %)
0 diff
(100 %id)
AY560594   .h 1 to 2802 1 to 2802 K224T tiling clone,   2802/2802
(100 %)
2 diff
(100.0 %id)
NM_003815.3   .h 1 to 2823 1 to 2823 exact RefSeq,   2823/2823
(100 %)
3 diff
(99.9 %id)
BX342790   .h 12 to 757 1 to 742       742/746
(99 %)
12 diff
(98.4 %id)
BX443140 B cells (Ramos cell line) .h 20 to 1100 1 to 1069       1071/1069
(100 %)
19 diff
(98.3 %id)
BC014566 Kidney, renal cell adenocarcinoma .h 21 to 2812 1 to 2792   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 2792/2792
(100 %)
2 diff
(100.0 %id)
AL522044 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .h 25 to 898 1 to 871       871/871
(100 %)
13 diff
(98.6 %id)
BX360706 Placenta Cot 25-normalized .h 39 to 992 1 to 945       945/949
(99 %)
16 diff
(98.4 %id)
AL551456 placenta, Placenta Cot 25-normalized .h 50 to 1060 1 to 1001       1001/1032
(96 %)
22 diff
(97.9 %id)
AL525717 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .h 80 to 1051 1 to 969       969/969
(100 %)
8 diff
(99.2 %id)
BX332914 Neuroblastoma Cot 25-normalized .h 80 to 1222 1 to 1122       1122/1136
(98 %)
37 diff
(96.8 %id)
BX384867   .h 84 to 1097 1 to 1021       1021/1021
(100 %)
24 diff
(97.7 %id)
DA646802 mammary gland .h 88 to 777 2 to 695   capped   694/728
(95 %)
8 diff
(99.0 %id)
U41767   .h 95 to 2819 1 to 2725   tiling clone, AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 2725/2725
(100 %)
2 diff
(100.0 %id)
BT009764   .h 102 to 2544 1 to 2443       2443/2445
(99 %)
4 diff
(99.9 %id)
U46005 umbilical vein .h 102 to 2819 1 to 2718       2718/2720
(99 %)
4 diff
(99.9 %id)
AL513878 placenta .h 602 to 1692 1 to 1083       1083/1098
(98 %)
39 diff
(96.5 %id)
AL575016 placenta, Placenta Cot 25-normalized .h 1684 to 2747 1094 to 37       1058/1098
(96 %)
34 diff
(97.0 %id)
AL562588 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .h 1773 to 2757 1011 to 31       979/1018
(96 %)
5 diff
(99.6 %id)
BX384866   .h 1808 to 2721 906 to 3       904/1027
(88 %)
30 diff
(97.1 %id)
BX360705 Placenta Cot 25-normalized .h 1815 to 2782 958 to 1       958/962
(99 %)
17 diff
(98.3 %id)
BX332913 Neuroblastoma Cot 25-normalized .h 1825 to 2737 968 to 52       917/920
(99 %)
6 diff
(99.4 %id)
TI_159722781   .h 1873 to 2819 1022 to 78   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 945/1043
(90 %)
20 diff
(98.1 %id)
AL522043 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .h 1883 to 2707 824 to 1       824/824
(100 %)
7 diff
(99.2 %id)
BQ723768 sympathetic trunk .h 1884 to 2707 1 to 834       834/928
(89 %)
16 diff
(98.3 %id)
BX333273 Neuroblastoma Cot 25-normalized .h 1907 to 2781 875 to 1       875/952
(91 %)
43 diff
(95.5 %id)
BM726389 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 1930 to 2409 1 to 480   fully sequenced, Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 480/480
(100 %)
0 diff
(100 %id)
BX435853 B cells (Ramos cell line) .h 1934 to 2818 890 to 1       890/913
(97 %)
25 diff
(97.3 %id)
AL513877 placenta .h 1939 to 2819 879 to 1       879/966
(90 %)
41 diff
(95.8 %id)
BX342789   .h 2007 to 2764 769 to 9       761/862
(88 %)
8 diff
(99.1 %id)
TI_149291376   .h 2019 to 2819 882 to 82   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 801/928
(86 %)
0 diff
(100 %id)
CB853121 Human Lung Epithelial cells, lung .h 2033 to 2819 804 to 19   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 786/786
(100 %)
8 diff
(99.0 %id)
BM824999 Ascites, stomach .h 2041 to 2573 1 to 533       533/542
(98 %)
1 diff
(99.9 %id)
AW072364 pooled .h 2055 to 2819 762 to 2       761/762
(99 %)
18 diff
(97.7 %id)
AI683885 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .h 2064 to 2819 789 to 28   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 703/771
(91 %)
27 diff
(96.5 %id)
CA313535 Human Lung Epithelial cells, lung .h 2068 to 2819 770 to 19   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 752/752
(100 %)
1 diff
(99.9 %id)
AA007462 liver and spleen .h 2079 to 2429 1 to 353   fully sequenced,   353/353
(100 %)
7 diff
(98.1 %id)
AA156581 Pancreas .h 2096 to 2204 7 to 115       109/115
(94 %)
6 diff
(94.8 %id)
CR603003 HeLa cells Cot 25-normalized .h 2105 to 2819 1 to 715       715/715
(100 %)
0 diff
(100 %id)
BX362636   .h 2105 to 2819 1 to 715   fully sequenced,   715/715
(100 %)
1 diff
(99.9 %id)
BM723724 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 2107 to 2818 1 to 712   fully sequenced, Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 712/712
(100 %)
2 diff
(99.8 %id)
TI_149287232   .h 2114 to 2819 803 to 98   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 706/706
(100 %)
7 diff
(99.1 %id)
BM973999 lung .h 2127 to 2819 711 to 19   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 693/693
(100 %)
0 diff
(100 %id)
TI_149285706   .h 2140 to 2819 795 to 116   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 680/680
(100 %)
6 diff
(99.2 %id)
BU625765 cell lines, Enchondroma .h 2151 to 2819 687 to 19   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 669/669
(100 %)
1 diff
(99.9 %id)
CA425672 cell lines, Chondrosarcoma .h 2152 to 2819 685 to 19   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 667/667
(100 %)
1 diff
(99.9 %id)
BX351123 Neuroblastoma Cot 25-normalized .h 2171 to 2776 613 to 9       605/776
(77 %)
13 diff
(98.4 %id)
R82416 placenta .h 2190 to 2474 1 to 288       288/433
(66 %)
4 diff
(99.1 %id)
BX090550 placenta .h 2195 to 2813 1 to 619   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 619/619
(100 %)
1 diff
(99.9 %id)
AI935176 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .h 2205 to 2819 618 to 7       612/618
(99 %)
3 diff
(99.6 %id)
BX374307   .h 2208 to 2817 613 to 1       613/662
(92 %)
36 diff
(94.6 %id)
BQ956670 large cell carcinoma, lung .h 2211 to 2819 1 to 609       609/610
(99 %)
1 diff
(99.9 %id)
BM971597 lung .h 2212 to 2819 627 to 19   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 609/609
(100 %)
2 diff
(99.7 %id)
BF435753 pooled .h 2217 to 2815 610 to 12   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 599/599
(100 %)
20 diff
(96.7 %id)
BI222883 cervical carcinoma cell line, cervix .h 2240 to 2819 1 to 579       579/612
(94 %)
4 diff
(99.4 %id)
BQ445999 Knee, Osteoarthritic Cartilage .h 2259 to 2819 579 to 19   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 561/561
(100 %)
7 diff
(98.8 %id)
DR421615 eye, Pterygium .h 2271 to 2764 1 to 494       494/494
(100 %)
0 diff
(100 %id)
AL047648 uterus .h 2278 to 2819 555 to 14   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 542/542
(100 %)
2 diff
(99.7 %id)
BM972580 lung .h 2279 to 2819 559 to 19   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 541/541
(100 %)
1 diff
(99.9 %id)
BU630257 cell lines, Chondrosarcoma .h 2291 to 2819 547 to 19   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 529/529
(100 %)
0 diff
(100 %id)
BQ188679 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 2296 to 2819 1 to 524   fully sequenced, AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 524/524
(100 %)
2 diff
(99.7 %id)
DB361562 mammary gland .h 2307 to 2819 508 to 1       508/517
(98 %)
16 diff
(97.0 %id)
TI_151733020   .h 2307 to 2819 597 to 85   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 513/1001
(51 %)
1 diff
(100.0 %id)
AA678849   .h 2309 to 2819 512 to 7       506/512
(98 %)
8 diff
(98.5 %id)
BF061328 pooled .h 2309 to 2819 520 to 12       509/520
(97 %)
4 diff
(99.3 %id)
AI312604 lung .h 2344 to 2818 475 to 1       475/478
(99 %)
4 diff
(99.2 %id)
AA643143 epithelium (cell line), Prostate .h 2347 to 2819 505 to 38   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 468/468
(100 %)
9 diff
(98.1 %id)
BX362635   .h 2348 to 2789 442 to 1   fully sequenced,   442/442
(100 %)
1 diff
(99.8 %id)
BM681562 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 2348 to 2815 484 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 468/468
(100 %)
0 diff
(100 %id)
BM681909 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 2348 to 2819 490 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 472/472
(100 %)
1 diff
(99.8 %id)
AA847243 colon, colon tumor .h 2355 to 2819 479 to 17   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 463/463
(100 %)
17 diff
(96.4 %id)
AI493659 B-cell, chronic lymphotic leukemia .h 2355 to 2819 486 to 23   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 464/464
(100 %)
3 diff
(99.4 %id)
AA155587 Pancreas .h 2363 to 2818 456 to 5       452/456
(99 %)
2 diff
(99.6 %id)
AW469364 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .h 2372 to 2541 170 to 1       170/181
(93 %)
13 diff
(92.9 %id)
AW467557 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .h 2376 to 2819 444 to 1       444/448
(99 %)
1 diff
(99.8 %id)
BM824762 Ascites, stomach .h 2380 to 2816 1 to 437       437/437
(100 %)
0 diff
(100 %id)
BE220799 malignant melanoma, metastatic to lymphnode, skin .h 2383 to 2819 439 to 2       438/571
(76 %)
4 diff
(99.3 %id)
AI991180 colon, colonic mucosa from 3 patients with Crohn'sdisease .h 2384 to 2541 157 to 1       157/157
(100 %)
1 diff
(99.4 %id)
AA577569 colon, colon tumor .h 2385 to 2819 466 to 35   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 432/432
(100 %)
5 diff
(98.9 %id)
AA730177 pooled germ cell tumors .h 2385 to 2819 436 to 12   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 425/492
(86 %)
19 diff
(96.2 %id)
AI688016 colon .h 2394 to 2819 427 to 2       426/427
(99 %)
0 diff
(100 %id)
AW166487 cervix .h 2395 to 2541 148 to 1       148/154
(96 %)
9 diff
(94.2 %id)
AI720377 colon .h 2398 to 2819 424 to 1       424/435
(97 %)
8 diff
(98.2 %id)
AA007366 liver and spleen .h 2399 to 2819 426 to 1   fully sequenced,   423/423
(100 %)
12 diff
(97.2 %id)
BM714151 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 2399 to 2811 1 to 413       413/413
(100 %)
1 diff
(99.8 %id)
BQ775998 Bone, Human Chondrosarcoma Cell Line .h 2404 to 2819 434 to 19   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 416/416
(100 %)
0 diff
(100 %id)
AA565906 colon, tumor .h 2408 to 2819 419 to 10       410/419
(97 %)
2 diff
(99.6 %id)
F24616 pectoral muscle (after mastectomy) .h 2410 to 2802 15 to 407       393/407
(96 %)
8 diff
(98.1 %id)
AW075299 colon, juvenile granulosa tumor .h 2416 to 2819 444 to 45   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 400/456
(87 %)
55 diff
(88.0 %id)
F36478 pectoral muscle (after mastectomy) .h 2420 to 2545 1 to 122       122/122
(100 %)
7 diff
(94.3 %id)
CK300163 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 2426 to 2819 412 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 394/394
(100 %)
0 diff
(100 %id)
CA433907 mixed .h 2426 to 2825 431 to 32   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 400/400
(100 %)
6 diff
(98.5 %id)
N94442 senescent fibroblast .h 2429 to 2819 401 to 6       396/454
(87 %)
9 diff
(98.1 %id)
H69221 liver and spleen .h 2459 to 2818 357 to 1       357/357
(100 %)
4 diff
(98.9 %id)
EC584065 Prostate .h 2460 to 2574 1 to 115       115/115
(100 %)
0 diff
(100 %id)
R70393.
matches multiple genes
breast .h 2505 to 2784 282 to 1     also hits gene DUSP22 282/345
(81 %)
5 diff
(98.6 %id)
R82359 placenta .h 2526 to 2812 288 to 3       286/288
(99 %)
0 diff
(100 %id)
BM148286 leukopheresis .h 2526 to 2819 332 to 37   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 296/296
(100 %)
8 diff
(97.3 %id)
EC583101 Prostate .h 2548 to 2654 1 to 107       107/107
(100 %)
1 diff
(99.1 %id)
CA308839 Alveolar Macrophage, lung .h 2563 to 2819 275 to 19   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 257/266
(96 %)
0 diff
(100 %id)
AA292676 ovarian tumor, ovary .h 2596 to 2819 238 to 8       231/238
(97 %)
0 diff
(100 %id)
AI364436 serous papillary carcinoma, high grade, 2pooled tumors, uterus .h 2615 to 2819 213 to 9       205/213
(96 %)
0 diff
(100 %id)
DR977627 brain .h 2623 to 2813 1 to 189   AAA Submitted on the opposite strand 189/189
(100 %)
7 diff
(96.3 %id)
AW079228 colon, juvenile granulosa tumor .h 2630 to 2819 196 to 7       190/196
(96 %)
0 diff
(100 %id)
AI380702 B-cell, chronic lymphotic leukemia .h 2703 to 2819 130 to 14   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 117/117
(100 %)
0 diff
(100 %id)
EC484571 Prostate .h 2707 to 2807 108 to 10       99/109
(90 %)
0 diff
(100 %id)
BE241439 leukopheresis .h 2719 to 2819 100 to 1       100/112
(89 %)
5 diff
(95.6 %id)
EC448158 Prostate .h 2731 to 2819 1 to 91       91/93
(97 %)
10 diff
(89.3 %id)
AB209157 brain .i 1 to 4508 1 to 4508 K169T tiling clone,   4508/4508
(100 %)
4 diff
(100.0 %id)
AU077005   .i 356 to 491 10 to 145       136/145
(93 %)
7 diff
(95.2 %id)
AU106276   .i 359 to 408 1 to 50       50/50
(100 %)
0 diff
(100 %id)
AU106272   .i 368 to 417 1 to 50       50/50
(100 %)
0 diff
(100 %id)
AU106275   .i 368 to 417 1 to 50       50/50
(100 %)
0 diff
(100 %id)
BM828604 Ascites, stomach .i 369 to 523 1 to 155       155/161
(96 %)
2 diff
(98.8 %id)
AU106271   .i 399 to 447 1 to 49       49/50
(98 %)
2 diff
(96.0 %id)
DA374080 thalamus .i 400 to 936 2 to 539   capped   538/538
(100 %)
3 diff
(99.5 %id)
DB283668 uterus .i 400 to 876 2 to 479   capped   478/478
(100 %)
1 diff
(99.8 %id)
AU106273   .i 406 to 455 1 to 50       50/50
(100 %)
0 diff
(100 %id)
AU106274   .i 406 to 455 1 to 50       50/50
(100 %)
0 diff
(100 %id)
AU106280   .i 406 to 455 1 to 50       50/50
(100 %)
0 diff
(100 %id)
AU106281   .i 406 to 455 1 to 50       50/50
(100 %)
0 diff
(100 %id)
BQ686551 ductal carcinoma, cell line, Pancreas .i 1727 to 2602 1 to 880       878/881
(99 %)
8 diff
(99.1 %id)
BG248350 adenocarcinoma cell line, colon .i 1740 to 2540 1 to 805       805/1176
(68 %)
30 diff
(97.5 %id)
CX786991 human embryonic stem cells .i 1810 to 2628 1 to 818       811/818
(99 %)
2 diff
(99.8 %id)
BI334666 cervical carcinoma cell line, cervix .i 1865 to 2560 1 to 701       701/783
(89 %)
23 diff
(97.1 %id)
BE548079 cervical carcinoma cell line, cervix .i 1876 to 2558 1 to 689       689/893
(77 %)
22 diff
(97.6 %id)
AL602333 human skeletal muscle .i 1913 to 2560 1 to 648       648/651
(99 %)
7 diff
(99.0 %id)
CX783952 human embryonic stem cells .i 1919 to 2627 1 to 708       708/708
(100 %)
3 diff
(99.6 %id)
BG115110 duodenal adenocarcinoma, cell line, small intestine .i 1922 to 2560 1 to 633       633/947
(66 %)
12 diff
(98.8 %id)
BM018308 astrocytoma grade IV, cell line, brain .i 1942 to 2579 1 to 656       653/656
(99 %)
27 diff
(95.9 %id)
BM910958 astrocytoma grade IV, cell line, brain .i 1942 to 2560 17 to 636       620/1155
(53 %)
20 diff
(98.3 %id)
TI_59388895   .i 1942 to 2579 96 to 751       653/656
(99 %)
27 diff
(95.9 %id)
CD516429 White Matter .i 1985 to 2835 1 to 853       853/853
(100 %)
5 diff
(99.5 %id)
BM018789 astrocytoma grade IV, cell line, brain .i 2004 to 2897 1 to 886       886/906
(97 %)
25 diff
(97.3 %id)
TI_59389458   .i 2005 to 2897 96 to 980       885/905
(97 %)
25 diff
(97.3 %id)
BG285217 adenocarcinoma, cell line, Prostate .i 2020 to 2743 1 to 721       721/795
(90 %)
11 diff
(98.7 %id)
BU168243 large cell carcinoma, lung .i 2039 to 2794 25 to 786   tiling clone,   762/909
(83 %)
23 diff
(97.5 %id)
DB153924 thymus .i 2052 to 2629 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
BE616698 adenocarcinoma, Pancreas .i 2059 to 2865 1 to 808       808/808
(100 %)
40 diff
(95.1 %id)
BM083389 adenocarcinoma, Pancreas .i 2064 to 2560 7 to 504       498/561
(88 %)
9 diff
(98.4 %id)
BP264630 umbilical vein .i 2066 to 2628 1 to 563       563/563
(100 %)
7 diff
(98.8 %id)
BE278487 choriocarcinoma, placenta .i 2080 to 2754 1 to 669       669/741
(90 %)
11 diff
(98.6 %id)
BE900970 choriocarcinoma, placenta .i 2082 to 2760 1 to 672       672/872
(77 %)
17 diff
(98.1 %id)
BE530998 adenocarcinoma, Pancreas .i 2083 to 2702 1 to 621       621/621
(100 %)
5 diff
(99.2 %id)
BE614921 adenocarcinoma, Pancreas .i 2084 to 2759 1 to 669       671/999
(67 %)
20 diff
(98.0 %id)
BE615531 adenocarcinoma, Pancreas .i 2085 to 2870 1 to 775       775/777
(99 %)
21 diff
(97.3 %id)
BE614705 adenocarcinoma, Pancreas .i 2086 to 2790 1 to 695       695/973
(71 %)
18 diff
(98.2 %id)
BP255737 Kidney .i 2135 to 2715 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP305351   .i 2138 to 2716 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
DA881174   .i 2140 to 2691 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
DA924985 small intestine .i 2141 to 2709 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BP253371 Kidney .i 2142 to 2704 1 to 561       561/561
(100 %)
7 diff
(98.8 %id)
BP253519 Kidney .i 2143 to 2724 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP252598 Kidney .i 2146 to 2726 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
CB145435 Liver .i 2146 to 2592 1 to 447       447/447
(100 %)
3 diff
(99.4 %id)
DA477358   .i 2147 to 2708 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA697641   .i 2149 to 2676 2 to 529   capped   528/528
(100 %)
1 diff
(99.9 %id)
CA488617   .i 2174 to 2940 1 to 770       770/883
(87 %)
5 diff
(99.5 %id)
DA443492 tongue, tumor tissue .i 2178 to 2767 2 to 591   capped   590/590
(100 %)
2 diff
(99.7 %id)
CB152671 brain .i 2181 to 2663 1 to 483       483/483
(100 %)
4 diff
(99.2 %id)
CB152365 brain .i 2181 to 2693 1 to 513       513/513
(100 %)
3 diff
(99.5 %id)
CB153939 brain .i 2181 to 2726 1 to 546       546/546
(100 %)
3 diff
(99.5 %id)
DB118549 thymus .i 2181 to 2740 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
BG254963 adenocarcinoma, cell line, Prostate .i 2187 to 2900 1 to 709       709/711
(99 %)
21 diff
(97.1 %id)
BE272584 Kidney, renal cell adenocarcinoma .i 2192 to 2813 1 to 620       620/620
(100 %)
4 diff
(99.4 %id)
BU183266 adenocarcinoma, Pancreas .i 2199 to 2970 1 to 776       776/948
(81 %)
11 diff
(98.9 %id)
DA718041   .i 2210 to 2676 2 to 468   capped   467/467
(100 %)
2 diff
(99.6 %id)
BF037690 adenocarcinoma, ovary .i 2242 to 2970 1 to 722       722/841
(85 %)
9 diff
(99.0 %id)
BE707436 head_neck .i 2243 to 2625 388 to 6       383/388
(98 %)
0 diff
(100 %id)
BE784428 large cell carcinoma, lung .i 2246 to 3075 1 to 828       828/990
(83 %)
34 diff
(96.6 %id)
BG698603 skin .i 2269 to 2933 1 to 664       664/664
(100 %)
5 diff
(99.3 %id)
BQ685904 ductal carcinoma, cell line, Pancreas .i 2277 to 2909 1 to 638       639/919
(69 %)
20 diff
(97.9 %id)
BQ879289 dorsal root ganglia .i 2290 to 3106 1 to 820       820/825
(99 %)
12 diff
(98.6 %id)
CD617590   .i 2292 to 3037 13 to 757       745/757
(98 %)
7 diff
(99.1 %id)
BG333274 large cell carcinoma, lung .i 2332 to 2865 1 to 534       534/534
(100 %)
1 diff
(99.9 %id)
BX370725   .i 2345 to 3270 1 to 925       925/928
(99 %)
8 diff
(99.2 %id)
BM055244 Islets of Langerhans, Pancreas .i 2380 to 2942 1 to 563       563/563
(100 %)
0 diff
(100 %id)
BM127411 Islets of Langerhans, Pancreas .i 2382 to 2919 1 to 539       539/539
(100 %)
1 diff
(99.9 %id)
DA596873   .i 2393 to 2942 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
BM836603 Ascites, stomach .i 2411 to 2897 1 to 487       487/487
(100 %)
0 diff
(100 %id)
BE902049 choriocarcinoma, placenta .i 2428 to 3167 1 to 735       735/736
(99 %)
8 diff
(99.0 %id)
BF745888 breast .i 2441 to 2602 1 to 161       161/170
(94 %)
7 diff
(95.9 %id)
DA842514 placenta .i 2451 to 3014 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BI259501 cervical carcinoma cell line, cervix .i 2462 to 3366 1 to 910       910/954
(95 %)
28 diff
(97.1 %id)
BI259486 cervical carcinoma cell line, cervix .i 2463 to 3248 1 to 803       803/920
(87 %)
20 diff
(97.9 %id)
DA503992 brain .i 2465 to 3018 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
BG746978 adenocarcinoma cell line, colon .i 2505 to 3314 1 to 810       810/812
(99 %)
18 diff
(97.8 %id)
BM818678 stomach .i 2511 to 3088 1 to 578       578/578
(100 %)
0 diff
(100 %id)
BP220678 colon .i 2514 to 3068 1 to 555       555/555
(100 %)
1 diff
(99.9 %id)
BP353666   .i 2517 to 3096 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BU170531 epithelioid carcinoma, Pancreas .i 2518 to 3320 1 to 810       810/828
(97 %)
11 diff
(98.7 %id)
BP267371 thyroid .i 2518 to 3096 1 to 579       579/579
(100 %)
0 diff
(100 %id)
BP267375 thyroid .i 2518 to 3093 1 to 576       576/576
(100 %)
0 diff
(100 %id)
BP267861 thyroid .i 2518 to 3096 1 to 579       579/579
(100 %)
0 diff
(100 %id)
BP268253 thyroid .i 2518 to 3092 1 to 574       574/577
(99 %)
9 diff
(98.5 %id)
DA027885   .i 2525 to 3088 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BP263971 small intestine .i 2539 to 3121 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
CB270657 adipose .i 2541 to 3080 1 to 540       540/540
(100 %)
0 diff
(100 %id)
CK429713 eye, lacrimal gland .i 2541 to 3191 1 to 651       651/651
(100 %)
0 diff
(100 %id)
DA273778 corpus callosum .i 2542 to 3104 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BG254373 adenocarcinoma, cell line, Prostate .i 2556 to 3277 1 to 719       719/738
(97 %)
26 diff
(96.5 %id)
BF094319 uterus_tumor .i 2561 to 2740 30 to 210       181/210
(86 %)
6 diff
(97.2 %id)
BM804700 ovary (pool of 3) .i 2591 to 3526 29 to 963       935/965
(96 %)
9 diff
(99.1 %id)
CB853386 Human Lung Epithelial cells, lung .i 2597 to 3276 680 to 1       680/680
(100 %)
0 diff
(100 %id)
BE265551 lung, small cell carcinoma .i 2615 to 3203 1 to 601       601/603
(99 %)
17 diff
(97.2 %id)
TI_57198097   .i 2618 to 3366 45 to 792       748/792
(94 %)
7 diff
(99.2 %id)
DA384504 thalamus .i 2625 to 3146 2 to 523   capped   522/522
(100 %)
1 diff
(99.9 %id)
BI822503 pooled brain, lung, testis .i 2627 to 3366 1 to 739       739/739
(100 %)
1 diff
(99.9 %id)
BF155163 breast .i 2640 to 2931 437 to 146       292/437
(66 %)
0 diff
(100 %id)
BE395441 endometrium, adenocarcinoma cell line, uterus .i 2641 to 3034 1 to 394       394/395
(99 %)
1 diff
(99.8 %id)
BG179893 adenocarcinoma, cell line, Prostate .i 2664 to 3268 1 to 602       602/602
(100 %)
7 diff
(98.9 %id)
TI_57215420   .i 2686 to 3566 33 to 910       878/1010
(86 %)
18 diff
(98.3 %id)
BI754485 brain .i 2694 to 3566 1 to 870       870/970
(89 %)
12 diff
(98.8 %id)
AA295191 Pancreas .i 2712 to 2975 1 to 264       264/264
(100 %)
0 diff
(100 %id)
BI255788 cervical carcinoma cell line, cervix .i 2715 to 3465 1 to 751       751/751
(100 %)
2 diff
(99.8 %id)
BP224439 colon mucosa .i 2729 to 3269 1 to 540       540/545
(99 %)
12 diff
(97.8 %id)
BE563547 adenocarcinoma, Pancreas .i 2765 to 3564 1 to 808       808/957
(84 %)
38 diff
(96.1 %id)
BE392593 endometrium, adenocarcinoma cell line, uterus .i 2784 to 3316 1 to 535       535/535
(100 %)
4 diff
(99.3 %id)
BI752057 brain .i 2786 to 3367 173 to 757       585/810
(72 %)
8 diff
(99.1 %id)
TI_57215080   .i 2786 to 3367 238 to 822       585/875
(66 %)
8 diff
(99.1 %id)
BG179653 adenocarcinoma, cell line, Prostate .i 2807 to 3566 1 to 758       758/1075
(70 %)
23 diff
(97.9 %id)
BQ891711 carcinoma, cell line, Prostate .i 2807 to 3642 1 to 841       841/893
(94 %)
11 diff
(98.8 %id)
BU502598 carcinoma, cell line, Prostate .i 2807 to 3643 1 to 841       841/938
(89 %)
17 diff
(98.2 %id)
BG697703 skin .i 2808 to 3599 1 to 794       794/795
(99 %)
4 diff
(99.5 %id)
BP252190 Kidney .i 2813 to 3393 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BG254075 adenocarcinoma, cell line, Prostate .i 2836 to 3524 1 to 687       687/743
(92 %)
8 diff
(99.0 %id)
BU502637 carcinoma, cell line, Prostate .i 2840 to 3364 70 to 593       524/1256
(41 %)
18 diff
(98.6 %id)
BP272860   .i 2854 to 3406 1 to 553       553/553
(100 %)
12 diff
(97.9 %id)
BG766182 melanotic melanoma, high MDR (cell line), skin .i 2856 to 3707 1 to 847       847/851
(99 %)
15 diff
(98.3 %id)
BE254262 eye, retinoblastoma .i 2859 to 3477 1 to 618       618/618
(100 %)
1 diff
(99.9 %id)
BE258436 eye, retinoblastoma .i 2859 to 3386 1 to 533       533/534
(99 %)
7 diff
(98.7 %id)
BG031380 breast, mammary adenocarcinoma, cell line .i 2859 to 3566 1 to 698       698/914
(76 %)
16 diff
(98.3 %id)
BG488647 large cell carcinoma, lung .i 2867 to 3474 1 to 608       608/608
(100 %)
0 diff
(100 %id)
AA380942   .i 2875 to 3107 1 to 232       232/232
(100 %)
5 diff
(97.9 %id)
BP266000 thyroid .i 2877 to 3457 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
BG760444 melanotic melanoma, high MDR (cell line), skin .i 2907 to 3841 1 to 945       917/945
(97 %)
29 diff
(97.0 %id)
BG766668 melanotic melanoma, high MDR (cell line), skin .i 2907 to 3744 1 to 840       840/840
(100 %)
14 diff
(98.4 %id)
BI255434 cervical carcinoma cell line, cervix .i 2908 to 3643 1 to 733       735/739
(99 %)
7 diff
(99.1 %id)
BI255369 cervical carcinoma cell line, cervix .i 2908 to 3545 1 to 657       657/846
(77 %)
12 diff
(98.6 %id)
EC523857 Prostate .i 2917 to 3008 92 to 1       92/92
(100 %)
0 diff
(100 %id)
CA495340   .i 2918 to 3715 1 to 811       811/861
(94 %)
15 diff
(98.3 %id)
BP256943 Kidney .i 2921 to 3493 1 to 573       573/573
(100 %)
1 diff
(99.9 %id)
CB128874 Liver .i 2922 to 3496 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
BM479000 melanotic melanoma, skin .i 2926 to 3564 1 to 640       640/1205
(53 %)
12 diff
(99.1 %id)
AL047647 uterus .i 2927 to 3258 1 to 332       332/334
(99 %)
2 diff
(99.5 %id)
BM990661 lung, Lung Focal Fibrosis .i 2933 to 3594 19 to 678     Submitted on the opposite strand 660/660
(100 %)
2 diff
(99.7 %id)
BF182963 large cell carcinoma, lung .i 2940 to 3682 1 to 734       673/734
(91 %)
22 diff
(97.1 %id)
BP303265   .i 2968 to 3549 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BF037242 adenocarcinoma, ovary .i 2997 to 3643 1 to 636       634/911
(69 %)
16 diff
(98.3 %id)
R69500.
matches multiple genes
breast .i 3030 to 3320 1 to 295     also hits gene DUSP22 295/297
(99 %)
10 diff
(96.7 %id)
CA454491   .i 3034 to 3808 1 to 782       782/913
(85 %)
20 diff
(97.9 %id)
DA072799 cerebellum .i 3046 to 3623 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
BM793873 Ascites, stomach .i 3046 to 3681 1 to 636   tiling clone,   636/636
(100 %)
0 diff
(100 %id)
CA489029   .i 3432 to 4199 1 to 786   tiling clone,   784/907
(86 %)
28 diff
(97.0 %id)
BF855434 prostate_normal .i 3502 to 4013 510 to 1     Submitted on the opposite strand 510/516
(98 %)
6 diff
(98.9 %id)
BQ335785 marrow .i 3649 to 3992 1 to 350       350/383
(91 %)
9 diff
(97.7 %id)
AI660841 colon, colonic mucosa from 3 patients with Crohn'sdisease .i 4039 to 4508 481 to 12   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 470/470
(100 %)
0 diff
(100 %id)
BX460518 brain, fetal brain .j -8 to 939 8 to 953   tiling clone,   948/953
(99 %)
10 diff
(99.0 %id)
BM921998 pooled brain, lung, testis .j 1696 to 2499 10 to 820   tiling clone,   809/907
(89 %)
10 diff
(98.9 %id)
BX455109 brain, fetal brain .j 2083 to 2812 728 to 1   tiling clone,   728/873
(83 %)
29 diff
(96.7 %id)
AY576417   .k 1 to 3016 1 to 3016 K224T tiling clone,   3016/3016
(100 %)
2 diff
(100.0 %id)
CK903492 Islets of Langerhans, Pancreas .k 2529 to 3033 517 to 13   tiling clone, AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 505/508
(99 %)
4 diff
(99.3 %id)
CK903493 Islets of Langerhans, Pancreas .k 2538 to 3033 1 to 496       496/496
(100 %)
0 diff
(100 %id)
BI964924 Islets of Langerhans, Pancreas .k 2553 to 2969 1 to 418       418/418
(100 %)
7 diff
(98.4 %id)
AV688253 hepatocellular carcinoma .k 2573 to 3007 1 to 435       435/436
(99 %)
7 diff
(98.4 %id)
AV688261 hepatocellular carcinoma .k 2573 to 3004 1 to 432       432/435
(99 %)
3 diff
(99.4 %id)
AY560595   .l 1 to 2804 1 to 2804 K224T tiling clone,   2804/2804
(100 %)
2 diff
(100.0 %id)
BM835367 stomach .m 1 to 471 2 to 473   tiling clone,   473/473
(100 %)
4 diff
(99.2 %id)
BP239298 Liver .m 36 to 611 1 to 576       576/576
(100 %)
2 diff
(99.7 %id)
AK295614 hippocampus .m 43 to 2697 1 to 2655 K208T P786S tiling clone,   2655/2655
(100 %)
3 diff
(99.9 %id)
DC332374 hippocampus .m 43 to 592 1 to 550       550/550
(100 %)
0 diff
(100 %id)
DC392297 stomach .m 45 to 599 1 to 555       555/555
(100 %)
0 diff
(100 %id)
CD672282 eye, Iris .m 2299 to 2750 1 to 452   tiling clone,   452/452
(100 %)
0 diff
(100 %id)
AI905147 breast .m 2343 to 2824 1 to 484       484/485
(99 %)
8 diff
(98.4 %id)
CF456896 peripheral nervous system .m 2521 to 2984 42 to 506       465/506
(91 %)
0 diff
(100 %id)
BF956592 nervous_normal .m 2525 to 3072 9 to 554   tiling clone,   546/554
(98 %)
16 diff
(97.2 %id)
BF956589 nervous_normal .m 2529 to 2985 1 to 457       457/458
(99 %)
18 diff
(96.1 %id)
CR976071 T-Lymphocytes .m 2767 to 2986 1 to 220       220/220
(100 %)
0 diff
(100 %id)
DC307180 cerebellum .n 1 to 502 5 to 506   tiling clone,   506/506
(100 %)
0 diff
(100 %id)
DC320134 brain .n 1 to 528 2 to 529       529/529
(100 %)
1 diff
(99.9 %id)
DC344061 thalamus .n 2 to 563 1 to 562       562/562
(100 %)
0 diff
(100 %id)
DC409871 thymus .n 5 to 598 1 to 594   tiling clone,   594/594
(100 %)
3 diff
(99.5 %id)
DC363601   .n 8 to 352 1 to 346       346/346
(100 %)
1 diff
(99.8 %id)
DC425873 brain .n 2361 to 2872 512 to 1   tiling clone,   512/512
(100 %)
1 diff
(99.9 %id)
AY560593   .o 1 to 2732 1 to 2732 K224T tiling clone,   2732/2732
(100 %)
2 diff
(100.0 %id)
NM_207191.1   .o 1 to 2753 1 to 2753 exact RefSeq,   2753/2753
(100 %)
3 diff
(99.9 %id)
AY518542   .o 102 to 2420 1 to 2319   tiling clone,   2319/2319
(100 %)
0 diff
(100 %id)
BQ953491 epidermoid carcinoma, cell line, lung .o 1664 to 2530 1 to 880       880/915
(96 %)
18 diff
(98.1 %id)
BU527380 epidermoid carcinoma, cell line, lung .o 1664 to 2402 1 to 745       745/866
(86 %)
10 diff
(98.9 %id)
BU528501 epidermoid carcinoma, cell line, lung .o 1664 to 2558 1 to 898       898/898
(100 %)
4 diff
(99.6 %id)
BQ922463 epidermoid carcinoma, cell line, lung .o 1725 to 2664 1 to 953       953/964
(98 %)
28 diff
(97.1 %id)
BG769181 melanotic melanoma, high MDR (cell line), skin .o 1886 to 2633 1 to 748       748/750
(99 %)
5 diff
(99.4 %id)
BU539532 adenocarcinoma, cell line, breast .o 2005 to 2675 1 to 677       677/852
(79 %)
8 diff
(99.1 %id)
BU607797 Human Lung Epithelial cells, lung .o 2019 to 2749 747 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 729/729
(100 %)
3 diff
(99.6 %id)
CA748879 Bone, Subchondral Bone .o 2019 to 2749 748 to 19   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 730/730
(100 %)
3 diff
(99.6 %id)
BM917252 blood, natural killer cells, cell line .o 2098 to 2749 678 to 24   AAA Submitted on the opposite strand 655/1109
(59 %)
15 diff
(98.7 %id)
BU631728 cell lines, Chondrosarcoma .o 2137 to 2749 631 to 19   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 613/613
(100 %)
2 diff
(99.7 %id)
BI963238 Islets of Langerhans, Pancreas .o 2305 to 2749 457 to 12       446/457
(97 %)
0 diff
(100 %id)
BX394949 Neuroblastoma Cot 25-normalized .p 1 to 989 1 to 980   tiling clone,   980/986
(99 %)
15 diff
(98.5 %id)
TI_57198042   .p 6 to 742 69 to 808       740/836
(88 %)
23 diff
(97.3 %id)
BI824530 pooled brain, lung, testis .p 7 to 770 1 to 767       767/767
(100 %)
19 diff
(97.6 %id)
DA647226 mammary gland .p 27 to 673 2 to 648   tiling clone, capped   647/648
(99 %)
2 diff
(99.7 %id)
AL524038 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .p 50 to 1090 1 to 1033   tiling clone,   1035/1077
(96 %)
18 diff
(98.4 %id)
AL524037 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .p 1600 to 2692 1089 to 7   tiling clone,   1083/1140
(95 %)
22 diff
(98.1 %id)
BX376327 Neuroblastoma Cot 25-normalized .p 1776 to 2673 898 to 1   tiling clone,   898/898
(100 %)
6 diff
(99.4 %id)
DB362084 mammary gland .p 2204 to 2717 512 to 1   tiling clone,   512/518
(98 %)
7 diff
(98.7 %id)
AL556598 placenta .q 1 to 1032 1 to 1025   tiling clone,   1025/1035
(99 %)
20 diff
(98.1 %id)
BG697588 skin .q 1555 to 2371 1 to 819   tiling clone,   817/819
(99 %)
6 diff
(99.3 %id)
CN399721 embryonic stem cells, cell lines H1, H7, andH9 .q 1572 to 2241 17 to 686       670/686
(97 %)
6 diff
(99.2 %id)
AW363499 colon .q 1575 to 1700 4 to 134       131/137
(95 %)
9 diff
(93.5 %id)
BU169027 ductal carcinoma, cell line, Pancreas .q 1610 to 2415 1 to 810       810/1026
(78 %)
19 diff
(98.2 %id)
BQ688517 ductal carcinoma, cell line, Pancreas .q 1610 to 2418 1 to 813       813/859
(94 %)
8 diff
(99.1 %id)
BM821954 stomach .q 1618 to 2113 1 to 495       495/495
(100 %)
1 diff
(99.8 %id)
CD617591   .q 1633 to 2191 562 to 3       560/562
(99 %)
4 diff
(99.3 %id)
CA397501 eye, RPE/choroid .q 1633 to 2206 1 to 574       574/574
(100 %)
1 diff
(99.9 %id)
CD671087 eye, Iris .q 1634 to 2140 1 to 507       507/507
(100 %)
4 diff
(99.3 %id)
BI334770 cervical carcinoma cell line, cervix .q 1645 to 2374 1 to 730       730/730
(100 %)
1 diff
(99.9 %id)
BG036468 adenocarcinoma, cell line, Prostate .q 1646 to 2350 1 to 696       696/940
(74 %)
17 diff
(98.2 %id)
CA488679   .q 1647 to 2138 1 to 498       498/807
(61 %)
16 diff
(98.1 %id)
BG251417 adenocarcinoma, cell line, Liver .q 1648 to 2302 9 to 658       650/925
(70 %)
12 diff
(98.8 %id)
BQ707592 Spleen .q 1648 to 2309 1 to 664       664/959
(69 %)
10 diff
(99.0 %id)
BQ711134 Spleen .q 1648 to 2350 1 to 704       704/917
(76 %)
19 diff
(98.0 %id)
AL578820 placenta .q 1734 to 2836 1088 to 1   tiling clone,   1088/1104
(98 %)
21 diff
(98.1 %id)
BE304864 adenocarcinoma cell line, colon .q 1738 to 2378 1 to 642       642/643
(99 %)
12 diff
(98.2 %id)
BG740329 skin .q 1763 to 2292 14 to 543       530/543
(97 %)
11 diff
(98.0 %id)
BF568738 epithelioid carcinoma cell line, Pancreas .q 1775 to 2290 1 to 515       515/515
(100 %)
5 diff
(99.1 %id)
CR990088 T-Lymphocytes .q 1800 to 2383 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
CA487716   .q 1810 to 2594 1 to 791       791/890
(88 %)
10 diff
(98.9 %id)
BF880857 lung_tumor .q 1862 to 2348 503 to 15     Submitted on the opposite strand 487/518
(94 %)
2 diff
(99.7 %id)
BF879482 lung_tumor .q 1865 to 2345 491 to 13     Submitted on the opposite strand 479/491
(97 %)
0 diff
(100 %id)
CA390051 eye, RPE/choroid .q 1884 to 2324 13 to 453       441/453
(97 %)
6 diff
(98.7 %id)
BF038135 adenocarcinoma, ovary .q 1905 to 2544 1 to 626       626/627
(99 %)
14 diff
(97.8 %id)
BM790519 Ascites, stomach .q 1968 to 2539 1 to 572   tiling clone,   572/572
(100 %)
0 diff
(100 %id)
BF905282 marrow .q 1981 to 2184 208 to 1     Submitted on the opposite strand 205/208
(98 %)
12 diff
(94.3 %id)
BE875463 large cell carcinoma, undifferentiated, lung .q 1991 to 2328 1 to 338       338/338
(100 %)
1 diff
(99.8 %id)
BQ335738 marrow .q 1998 to 2203 10 to 217       208/217
(95 %)
8 diff
(96.4 %id)
BQ371634 prostate_normal .q 2005 to 2402 406 to 13       394/406
(97 %)
1 diff
(99.8 %id)
AA297185 embryo .q 2030 to 2297 1 to 268       268/268
(100 %)
2 diff
(99.3 %id)
CD617582   .q 2030 to 2512 10 to 489       480/493
(97 %)
13 diff
(97.4 %id)
CD617583   .q 2030 to 2517 489 to 1       489/502
(97 %)
3 diff
(99.5 %id)
CD617584   .q 2030 to 2512 11 to 491       481/495
(97 %)
11 diff
(97.8 %id)
CD617585   .q 2030 to 2517 488 to 1       488/501
(97 %)
7 diff
(98.7 %id)
CD617587   .q 2030 to 2400 13 to 391       379/391
(96 %)
15 diff
(96.2 %id)
CD617588   .q 2030 to 2517 9 to 489       481/489
(98 %)
21 diff
(95.8 %id)
CD617589   .q 2054 to 2517 464 to 1       464/502
(92 %)
3 diff
(99.5 %id)
BG179366 adenocarcinoma, cell line, Prostate .q 2069 to 2348 9 to 288       280/288
(97 %)
6 diff
(98.0 %id)
BE877474 large cell carcinoma, undifferentiated, lung .q 2114 to 2328 1 to 215       215/215
(100 %)
0 diff
(100 %id)
BG028171 Bone, osteosarcoma, cell line .q 2115 to 2348 1 to 236       236/236
(100 %)
2 diff
(99.2 %id)
BI024760 marrow .q 2137 to 2544 11 to 418       408/426
(95 %)
8 diff
(98.2 %id)
CD617586   .q 2153 to 2531 380 to 7       374/380
(98 %)
18 diff
(95.3 %id)
EC509971 Prostate .q 2160 to 2254 1 to 93       93/93
(100 %)
2 diff
(97.9 %id)
BG255588 adenocarcinoma, cell line, Prostate .q 2211 to 2348 1 to 137       137/137
(100 %)
1 diff
(99.3 %id)
AW843362 colon_normal .q 2234 to 2349 127 to 13       115/127
(90 %)
0 diff
(100 %id)
EC525576 Prostate .q 2321 to 2420 1 to 98       98/99
(98 %)
5 diff
(95.0 %id)
AK297468 brain .r 1 to 1994 1 to 1994 G88C K175T tiling clone,   1994/1994
(100 %)
3 diff
(99.9 %id)
DC352109 brain .r 1 to 586 1 to 586       586/586
(100 %)
3 diff
(99.5 %id)
AW290953   .r 1716 to 2146 448 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 431/434
(99 %)
4 diff
(99.1 %id)
BF000387 colon, colon tumor, RER+ .r 1755 to 2146 403 to 12   AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 392/392
(100 %)
9 diff
(97.8 %id)
AW856176 colon .r 1919 to 2084 1 to 165       165/165
(100 %)
13 diff
(92.2 %id)
AK308172 placenta .s 1 to 929 1 to 929   tiling clone,   929/929
(100 %)
1 diff
(99.9 %id)
AL523834 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .s 17 to 1035 1 to 1014   tiling clone,   1014/1014
(100 %)
18 diff
(98.3 %id)
AW602149 breast .s 653 to 1024 8 to 380   tiling clone,   373/380
(98 %)
8 diff
(97.9 %id)
AL523833 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .s 1755 to 2708 944 to 1   tiling clone,   944/1059
(89 %)
38 diff
(96.5 %id)
DB224146 trachea .t 1 to 587 2 to 589   tiling clone, capped   588/588
(100 %)
1 diff
(99.9 %id)
BP268955 thyroid .t 352 to 932 1 to 580       580/580
(100 %)
4 diff
(99.4 %id)
BP269052 thyroid .t 352 to 936 1 to 584       584/584
(100 %)
4 diff
(99.4 %id)
BU174728 ductal carcinoma, cell line, Pancreas .t 356 to 1021 9 to 676       668/927
(72 %)
15 diff
(98.4 %id)
BQ901083 ductal carcinoma, cell line, Pancreas .t 358 to 890 1 to 535       535/1069
(50 %)
18 diff
(98.4 %id)
BG323724 Kidney, renal cell adenocarcinoma .t 364 to 1106 1 to 742       742/827
(89 %)
18 diff
(97.9 %id)
BI911412 leukocyte .t 387 to 1034 22 to 669       648/670
(96 %)
9 diff
(98.7 %id)
TI_57232151   .t 387 to 1034 22 to 669       648/670
(96 %)
9 diff
(98.7 %id)
BE272495 Kidney, renal cell adenocarcinoma .t 416 to 972 1 to 558       558/559
(99 %)
3 diff
(99.5 %id)
BE543671 cervical carcinoma cell line, cervix .t 432 to 1021 1 to 600       598/994
(60 %)
22 diff
(97.8 %id)
BG385358 adenocarcinoma cell line, colon .t 435 to 962 1 to 526   tiling clone,   528/526
(100 %)
4 diff
(99.3 %id)
DA445542 tongue, tumor tissue .t 442 to 1004 2 to 564   capped   563/563
(100 %)
3 diff
(99.5 %id)
DB002019 breast, tumor tissue .t 469 to 1008 2 to 541   capped   540/540
(100 %)
2 diff
(99.7 %id)
EC582617 Prostate .t 480 to 579 109 to 9       101/109
(92 %)
0 diff
(100 %id)
BE544618 cervical carcinoma cell line, cervix .t 504 to 1021 1 to 533       530/754
(70 %)
23 diff
(97.0 %id)
DA960232 Spleen .t 519 to 1072 2 to 555   capped   554/554
(100 %)
3 diff
(99.5 %id)
DA926875 small intestine .t 531 to 1111 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
BP313215 mammary gland .t 532 to 1102 1 to 571       571/582
(98 %)
2 diff
(99.7 %id)
DA573401   .t 619 to 1155 2 to 538   tiling clone, capped   537/537
(100 %)
1 diff
(99.9 %id)
DA110343 cerebellum .t 1039 to 1601 2 to 564   tiling clone, capped   563/564
(99 %)
1 diff
(99.9 %id)
CR614548 B cells (Ramos cell line) Cot 25-normalized .u 1 to 1112 8 to 1119 exact tiling clone,   1119/1119
(100 %)
0 diff
(100 %id)
DC382273 placenta .va 1 to 560 1 to 560 exact tiling clone,   560/560
(100 %)
1 diff
(99.9 %id)
AL043320 testis .vb-u 1 to 735 1 to 735 E133X G140X R145K P150X tiling clone,   735/735
(100 %)
3 diff
(99.6 %id)
DA104104 cerebellum .vc 1 to 551 2 to 552 exact tiling clone, capped   551/551
(100 %)
0 diff
(100 %id)
AW089482 ovary, tumor, 5 pooled (see description) .vc 539 to 1097 582 to 24   tiling clone, AAA Possibly primed on the genome, locally A rich (27/32 A in genome downstream of last aligned base) 559/559
(100 %)
15 diff
(97.4 %id)
BQ357105 head_neck .vc 819 to 1137 7 to 325   tiling clone,   319/349
(91 %)
4 diff
(98.9 %id)
DA186127 amygdala .vd 1 to 486 7 to 492 Q33R tiling clone, capped   491/491
(100 %)
1 diff
(99.8 %id)
BE930532 placenta_normal .ve 1 to 430 1 to 430 E3D tiling clone,   430/430
(100 %)
2 diff
(99.6 %id)
DA235184 brain .vf 1 to 594 2 to 598   tiling clone, capped   597/597
(100 %)
7 diff
(98.9 %id)
DA450855 tongue, tumor tissue .vf 267 to 838 2 to 574   tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
DA097571 cerebellum .vf 394 to 970 2 to 578 exact tiling clone, capped   577/577
(100 %)
1 diff
(99.9 %id)
AL596882   .vg 1 to 381 1 to 380 K5R T6L V7W E8S L9W ... tiling clone,   380/380
(100 %)
2 diff
(99.5 %id)
68 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb-u, .vc, .vd, .ve, .vf, .vg Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI